BTIG raises Roblox stock price target to $73, maintains Buy rating
BTIG analyst Clark Lampen adjusted the price target for Roblox Corp . (NYSE:RBLX) shares, raising it to $73 from the previous $66, while maintaining a Buy rating on the stock. The reevaluation ...
BTIG Sticks to Its Buy Rating for Haemonetics (HAE)
In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Haemonetics (HAE – Research Report), with a price target of ...
BTIG maintains Coya Therapeutics stock buy rating, $15 target
BTIG analysts upheld their Buy rating and $15.00 price target for Coya Therapeutics (NASDAQ:COYA), following recent clinical trial data. The stock, currently trading at $7.11, has shown strong ...
BTIG says Paysafe could be worth $40 in sale, sees suitors as strategic buyers
BTIG notes that Bloomberg reported earlier that Buy-rated Paysafe (PSFE) is exploring a sale after receiving takeover interest. The article ...
Paysafe may be worth $40 a share in potential takeover - analyst
Paysafe (PSFE) could be valued at $40 a share in a potential acquisition, as the payments firm explores sale options with strategic buyers, according to ...
K&F Growth Acquisition Corp. II Announces Completion of $287.5 million IPO
Each Unit Includes One Class A Ordinary Share and One Share Right to Receive 1/15th of a Class A Ordinary Share MANHATTAN BEACH, CA, Feb. 06, 2025 (GLOBE NEWSWIRE) -- K&F Growth Acquisition Corp. II ...
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...